` Comparison: ROSE vs 9776 - Alpha Spread

Z
ROSE
vs
9776

Over the past 12 months, ROSE has underperformed Sapporo Clinical Laboratory Inc, delivering a return of 0% compared to the Sapporo Clinical Laboratory Inc's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ROSE
9776
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Z
ROSE Intrinsic Value
Not Available
Intrinsic Value
1 258.042 JPY
Overvaluation 100%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Z
Zur Rose Group AG
SIX:ROSE
32.3 CHF
Sapporo Clinical Laboratory Inc
TSE:9776
999 999.9999 JPY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ROSE, 9776

ROSE
9776
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Z
Zur Rose Group AG
Revenue
Sapporo Clinical Laboratory Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ROSE, 9776

ROSE
9776
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Z
Zur Rose Group AG
SIX:ROSE
Sapporo Clinical Laboratory Inc
TSE:9776
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ROSE
15.3%
Sapporo Clinical Laboratory Inc
30.5%

Operating Margin

ROSE
-8.3%
Sapporo Clinical Laboratory Inc
3.7%

Net Margin

ROSE
-10.6%
Sapporo Clinical Laboratory Inc
2.4%

FCF Margin

ROSE
-9.7%
Sapporo Clinical Laboratory Inc
0.8%

ROE

ROSE
-48.8%
Sapporo Clinical Laboratory Inc
4.4%

ROA

ROSE
-15.6%
Sapporo Clinical Laboratory Inc
3%

ROIC

ROSE
-16.2%
Sapporo Clinical Laboratory Inc
4.4%

ROCE

ROSE
-15.6%
Sapporo Clinical Laboratory Inc
5.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ROSE, 9776

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ROSE, 9776

Loading
ROSE
9776
Difference
www.alphaspread.com

Performance By Year
ROSE, 9776

Loading
ROSE
9776
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ROSE to other stocks
CLS
Clicks Group Ltd
C
Cheaper
vs ROSE
DCP
Dis-Chem Pharmacies Ltd
D
Cheaper
vs ROSE
WBA
Walgreens Boots Alliance...
Cheaper
vs ROSE
RADL3
Raia Drogasil SA
Cheaper
vs ROSE
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett